Identification and antifungal susceptibility patterns of Candida species isolated from blood cultures

Abstract

Background and Objectives:: Candidemia is an important cause of healthcare-associated bloodstream infection, and changes in the distribution of Candida species may influence antifungal treatment strategies. This study aimed to determine the species distribution of yeasts isolated from blood cultures and evaluate their antifungal susceptibility profiles.

Materials and Methods:: This retrospective study included 269 yeast isolates recovered from blood cultures between December 2017 and December 2021. Species identification was performed using the VITEK 2 YST system. Antifungal susceptibility testing was performed using Sensititre YeastOne for 215 (79.9%) isolates and VITEK 2 AST-YS08 for 54 (20.1%). Minimum inhibitory concentration results were interpreted according to applicable CLSI species-specific clinical breakpoints.

Results:: Of the 269 isolates, 112 (41.6%) were Candida albicans and 157 (58.4%) were non-albicans Candida. The most frequent non-albicans species were C. parapsilosis (n=73, 27.1%), Nakaseomyces glabrata (C. glabrata) (n=37, 13.8%), and C. tropicalis (n=34, 12.6%). Fluconazole MIC50/MIC90 values were 0.5/256 mg/L for C. albicans, 1/16 mg/L for C. parapsilosis, 8/32 mg/L for C. glabrata, and 1/4 mg/L for C. tropicalis.

Conclusion:: The predominance of non-albicans Candida, particularly C. parapsilosis, highlights the importance of continuous local surveillance. Methodological differences between commercial susceptibility testing systems should be considered when interpreting antifungal susceptibility results.

Moraxella species isolated from blood cultures in Europe (MORAXEu): a multicentre study of epidemiology and antimicrobial susceptibility with complementary phylogenomic analysis of publicly available genomes
Tone Tønjum, Vinicius da Silva Franklin-Duarte, Johan Christian Berild +101
European Journal of Clinical Microbiology and Infectious Diseases5 Sep 2026Peer-reviewedLicence not statedEndocrinology & metabolismHAL
Dermatophytes in Argentina: species distribution, comparative identification accuracy of conventional and proteomic methods, introduction of a novel molecular identification approach, and antifungal susceptibility profiles
Natalia Sasoni, María Sol Barbagelata, Ivana Maldonado +7
Antimicrobial Agents and Chemotherapy1 Oct 2026Peer-reviewedCC BY 4.0Full textGeneral medicinePMC
Characterization and Antimicrobial Susceptibility Patterns of Clinically Significant Non-fermenting Gram-Negative Bacilli Isolated From Clinical Specimens
Dhanashree R Chavan, Ravindra V Shinde, Satish R Patil
Cureus16 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Rapid identification and antimicrobial susceptibility testing of pathogenic microorganisms from positive blood cultures
Wenna Xu, Xiaomin Liu, Nansong Xu +6
PLOS One23 Sep 2026Peer-reviewedCC BY 4.0Full textMicrobiology Pharmacology & toxicologyPLOS
Epidemiological and antimicrobial susceptibility patterns of Staphylococcus aureus isolated from the nasal cavity of healthcare personnel at a public hospital in Northeastern Brazil: a cross-sectional survey
Francisco Italo Gomes Alencar, Francisco Marques da Silva Neto, Nayara Maria Barbosa de Sousa +8
Brazilian Journal of Microbiology4 Nov 2026Peer-reviewedCC BY 4.0Full textInfectious diseasePMC

Cite

BibTeX RIS

BibTeX

@article{yousefi2026identification,
  title = {{Identification and antifungal susceptibility patterns of Candida species isolated from blood cultures}},
  author = {Peri Sohrabi Molla Yousefi},
  journal = {Iranian Journal of Microbiology},
  year = {2026},
  month = nov,
  doi = {10.18502/ijm.v18i5.22862},
  url = {https://doi.org/10.18502/ijm.v18i5.22862},
  note = {CC BY-NC 4.0},
}

RIS

TY  - JOUR
TI  - Identification and antifungal susceptibility patterns of Candida species isolated from blood cultures
AU  - Peri Sohrabi Molla Yousefi
PY  - 2026
DA  - 2026/11/06
JO  - Iranian Journal of Microbiology
DO  - 10.18502/ijm.v18i5.22862
UR  - https://doi.org/10.18502/ijm.v18i5.22862
AB  - Background and Objectives:: Candidemia is an important cause of healthcare-associated bloodstream infection, and changes in the distribution of Candida species may influence antifungal treatment strategies. This study aimed to determine the species distribution of yeasts isolated from blood cultures and evaluate their antifungal susceptibility profiles.  Materials and Methods:: This retrospective study included 269 yeast isolates recovered from blood cultures between December 2017 and December 2021. Species identification was performed using the VITEK 2 YST system. Antifungal susceptibility testing was performed using Sensititre YeastOne for 215 (79.9%) isolates and VITEK 2 AST-YS08 for 54 (20.1%). Minimum inhibitory concentration results were interpreted according to applicable CLSI species-specific clinical breakpoints.  Results:: Of the 269 isolates, 112 (41.6%) were Candida albicans and 157 (58.4%) were non-albicans Candida. The most frequent non-albicans species were C. parapsilosis (n=73, 27.1%), Nakaseomyces glabrata (C. glabrata) (n=37, 13.8%), and C. tropicalis (n=34, 12.6%). Fluconazole MIC50/MIC90 values were 0.5/256 mg/L for C. albicans, 1/16 mg/L for C. parapsilosis, 8/32 mg/L for C. glabrata, and 1/4 mg/L for C. tropicalis.  Conclusion:: The predominance of non-albicans Candida, particularly C. parapsilosis, highlights the importance of continuous local surveillance. Methodological differences between commercial susceptibility testing systems should be considered when interpreting antifungal susceptibility results.
SN  - 2008-3289
SN  - 2008-4447
ER  -

Abstract

Related

Cite